Bextra® Side Effects

Since Bextra® was introduced to consumers as a pain reliever for the symptoms of arthritis in 2001, a range of side effects have been reported. The more common, less dangerous side effects can include indigestion, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Additionally, Bextra® has caused ulcers and stomach bleeding in some cases. However, other serious conditions have recently been associated with Bextra® use, leading to a recall of the medication in April of 2005.

Dangerous Skin Reactions

Some patients taking Bextra® have acquired potentially life-threatening skin reactions, including Stevens-Johnson Syndrome and toxic epidermal necrolysis. Many of the allergic reactions occurred in patients with a known allergy to sulfa. Warning signs of adverse skin reactions include the appearance of a skin rash and sores inside of the mouth. Several reports of hospitalization and death have been associated with the skin conditions linked to Bextra®. Although other COX-2 inhibitors and NSAIDs have a risk for these skin conditions, the danger that Bextra® poses to patients is greater.

Cardiovascular Risks

Patients treated with Bextra® after coronary artery bypass graft (CAGB) surgery have an increased risk of cardiovascular problems. Some of these conditions include heart attack, stroke, and blood clots in the leg and lung. The danger of heart problems, in conjunction with the skin reactions linked to Bextra® use resulted in the FDA’s conclusion that the arthritis medication poses a serious threat to consumers and should be removed from the market.

If you or a loved one has suffered the adverse side effects of Bextra®, contact an experienced attorney for more information.

• Contact Us
• Bookmark Site